SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Windlas Biotech - Quaterly Results

08 Feb 2023 Evaluate
The quarter ended December 2022 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 1197.04 millions.Net profit stood at Rs. 91.88  millions  compared to Rs. 83.15 millions in the corresponding previous quarter,high by 10.50%.Operating profit for the quarter ended December 2022 rose to 161.11 millions as compared to 148.36 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1197.04 1175.91 1.80 3723.70 3437.99 8.31 4659.30 4276.02 8.96
Other Income 21.62 17.93 20.58 76.31 37.01 106.19 67.06 30.94 116.74
PBIDT 161.11 148.36 8.59 514.31 423.11 21.55 596.01 577.86 3.14
Interest 1.57 2.11 -25.59 6.22 11.29 -44.91 14.17 12.90 9.84
PBDT 159.54 146.25 9.09 508.09 411.82 23.38 581.84 241.45 140.98
Depreciation 31.35 31.45 -0.32 87.96 92.45 -4.86 121.47 129.65 -6.31
PBT 128.19 114.80 11.66 420.13 319.37 31.55 460.37 111.80 311.78
TAX 36.31 31.65 14.72 108.16 86.09 25.64 74.76 61.70 21.17
Deferred Tax 8.65 4.12 109.95 6.75 1.93 249.74 -26.57 13.28 -300.08
PAT 91.88 83.15 10.50 311.97 233.28 33.73 385.61 50.10 669.68
Equity 107.21 108.97 -1.62 108.97 108.97 0.00 108.97 64.11 69.97
PBIDTM(%) 13.46 12.62 6.68 13.81 12.31 12.23 12.79 13.51 -5.34

Windlas Biotech Share Price

876.00 10.60 (1.22%)
20-Apr-2026 14:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.40
Dr. Reddys Lab 1234.00
Cipla 1233.00
Zydus Lifesciences 939.55
Lupin 2330.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×